Sure, We'll (Eventually) Beat Cancer. But Can We Afford To?:
"Last year, MD Anderson oncologist Hagop Kantarjian launched a crusade against
current cancer drug prices, decrying the $100,000+ price tag for more than a dozen
therapies launched over the last two years that may come with minimal survival
gains for the median patient – measured in months or even weeks. Other
physicians at Memorial Sloan Kettering, ASCO, and beyond have joined with long
standing critics of the pharmaceutical industry to call for changes to the current
cancer drug pricing system, if not outright cancer drug price controls."
See:
http://www.forbes.com/sites/theapoth...-we-afford-to/